Prosecution Insights
Last updated: November 18, 2026

Cube Biotech GmbH

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Cube Biotech GmbH is active in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This workload is handled by 1 distinct examiner within 1 distinct art unit. This distribution indicates that the company's current patenting efforts are focused on a single point of review at the patent office.

The busiest examiner identified is HOU, FRANK S. This individual is assigned 1 pending office action. Because the company has 1 pending action, this examiner manages the entire active workload. This means that the prosecution strategy must be specifically tailored to the requirements and preferences of this single examiner.

The fact that there is 1 distinct art unit involved suggests that the technical scope of the pending matter is narrow. Practitioners should expect a consistent examination experience, as no other examiners or art units are currently involved. This results in a streamlined but singular prosecution path within the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOU, FRANK S 1 67.8% +36.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18263637 SOLUBLE CHELATOR FOR TARGETING RECOMBINANT PROTEINS HOU, FRANK S 26d

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18263637 SOLUBLE CHELATOR FOR TARGETING RECOMBINANT PROTEINS HOU, FRANK S 26d

Top Art Units

Art UnitApps
1692 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18263637 SOLUBLE CHELATOR FOR TARGETING RECOMBINANT PROTEINS HOU, FRANK S 1692 §102§103§112 Non-Final OA 26d Pending Jul 31, 2023

Managing Cube Biotech GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cube Biotech GmbH have?

Cube Biotech GmbH has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Cube Biotech GmbH applications?

Frank S Hou has the most, with 1 of Cube Biotech GmbH's pending office actions.

What technology area are Cube Biotech GmbH's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month